These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18386629)

  • 1. [Fulminant strongyloidiasis successfully treated by subcutaneous ivermectin: an autopsy case].
    Takashima N; Yazawa S; Ishihara A; Sugimoto S; Shiomi K; Hiromatsu K; Nakazato M
    Rinsho Shinkeigaku; 2008 Jan; 48(1):30-5. PubMed ID: 18386629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
    Turner SA; Maclean JD; Fleckenstein L; Greenaway C
    Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
    Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
    Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.
    Moura EB; Maia Mde O; Ghazi M; Amorim FF; Pinhati HM
    Braz J Infect Dis; 2012; 16(5):479-81. PubMed ID: 22975175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal change nephrotic syndrome in a patient with strongyloidiasis.
    Miyazaki M; Tamura M; Kabashima N; Serino R; Shibata T; Miyamoto T; Furuno Y; Nishio T; Ohara J; Sakurai T; Otsuji Y
    Clin Exp Nephrol; 2010 Aug; 14(4):367-71. PubMed ID: 20224878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C; Kinoshita K; Nozaki Y; Funauchi M
    BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report:
    De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
    Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
    [No Abstract]   [Full Text] [Related]  

  • 8. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.
    Leung V; Al-Rawahi GN; Grant J; Fleckenstein L; Bowie W
    Am J Trop Med Hyg; 2008 Dec; 79(6):853-5. PubMed ID: 19052292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
    Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
    J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of strongyloidiasis hyperinfection during oral corticosteroid therapy associated with a nephrotic patient infected with HTLV-1].
    Mitsunaga M; Miyauchi N; Akiyama Y; Saima S
    Nihon Ronen Igakkai Zasshi; 2003 Jul; 40(4):397-401. PubMed ID: 12934572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield of double-balloon enteroscopy with intestinal juice analysis for intestinal strongyloidiasis.
    Nakamura N; Matsushita M; Tahashi Y; Shimatani M; Aoi K; Yanagawa M; Okazaki K
    Dig Endosc; 2010 Oct; 22(4):370-2. PubMed ID: 21175501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: two case reports and a discussion of the literature.
    Barrett J; Broderick C; Soulsby H; Wade P; Newsholme W
    J Antimicrob Chemother; 2016 Jan; 71(1):220-5. PubMed ID: 26462990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
    Manrique-Rodríguez S; Martín-Rabadán P; Díaz-Cámara M; Fernández-Llamazares CM
    Med Clin (Barc); 2016 Apr; 146(8):376-7. PubMed ID: 26654554
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.
    Hauber HP; Galle J; Chiodini PL; Rupp J; Birke R; Vollmer E; Zabel P; Lange C
    Infection; 2005 Oct; 33(5-6):383-6. PubMed ID: 16258873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient.
    Martin SJ; Cohen PR; MacFarlane DF; Grossman ME
    Skinmed; 2011; 9(3):199-202. PubMed ID: 21675505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.
    Choksi TT; Madison G; Dar T; Asif M; Fleming K; Clarke L; Danilewitz M; Hennawy R
    Am J Trop Med Hyg; 2016 Oct; 95(4):864-867. PubMed ID: 27527631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Subcutaneous Ivermectin Pharmacokinetics in Disseminated
    Konecny P; Weatherall CJ; Adhikari S; Duflou J; Marjoniemi V; Pretorius CJ; McWhinney B
    Am J Trop Med Hyg; 2018 Dec; 99(6):1580-1582. PubMed ID: 30334520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.
    Bogoch II; Khan K; Abrams H; Nott C; Leung E; Fleckenstein L; Keystone JS
    Am J Trop Med Hyg; 2015 Jul; 93(1):94-6. PubMed ID: 25918215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus.
    Yoshida H; Endo H; Tanaka S; Ishikawa A; Kondo H; Nakamura T
    Mod Rheumatol; 2006; 16(1):44-7. PubMed ID: 16622724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
    Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.